|
64
|
237
|
5lexC |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
63
|
241
|
5l5uG |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
59
|
226
|
5l60H |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
65
|
230
|
5lf7A |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
47
|
222
|
5ln32 |
The human 26s proteasome at 6.8 ang. |
|
70
|
243
|
5l6bF |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
68
|
242
|
5l61D |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14 |
|
67
|
233
|
5l64M |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
69
|
233
|
5l5uM |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
65
|
211
|
5l5wK |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
67
|
200
|
5leyK |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
54
|
196
|
5lf3J |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
59
|
195
|
5l65J |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
43
|
221
|
5m32H |
Human 26s proteasome in complex with oprozomib |
|
58
|
204
|
5l5sI |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
63
|
211
|
5l5iK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
|
66
|
213
|
5lexL |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
63
|
241
|
5l62G |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
76
|
248
|
5leyB |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
68
|
240
|
5l6aC |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
70
|
243
|
5l68F |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
64
|
227
|
5lzp0 |
Binding of the c-terminal gqyl motif of the bacterial proteasome activator bpa to the 20s proteasome |
|
57
|
195
|
5l5zJ |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
54
|
196
|
5leyJ |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
66
|
216
|
5lf0M |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
62
|
244
|
5lf6G |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
70
|
243
|
5l61F |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14 |
|
67
|
242
|
5l62D |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
68
|
233
|
5l5xM |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
57
|
202
|
5lexN |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
59
|
196
|
5l5vN |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
67
|
211
|
5l60K |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
67
|
230
|
5lf4A |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
61
|
230
|
5lexA |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
70
|
244
|
5l61B |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14 |
|
69
|
244
|
5l63B |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
74
|
248
|
5lf1B |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
59
|
196
|
5l63N |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
55
|
248
|
5ln3D |
The human 26s proteasome at 6.8 ang. |
|
67
|
233
|
5l6bM |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
61
|
195
|
5l5vJ |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
66
|
237
|
5lf4C |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
44
|
218
|
5ln37 |
The human 26s proteasome at 6.8 ang. |
|
58
|
204
|
5l6cI |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
65
|
250
|
5l69A |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
66
|
240
|
5m2bC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
68
|
233
|
5l6cM |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
67
|
233
|
5l5vM |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
58
|
196
|
5l60N |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
57
|
202
|
5lf4N |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
